Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

EPA assesses cancer risk due to childhood carcinogen exposure.

Lindsey H.

Lancet Oncol. 2003 Apr;4(4):201. No abstract available.

PMID:
12681256
2.

Environmental factors in cancer: focus on air pollution.

Chameides WL.

Rev Environ Health. 2010 Jan-Mar;25(1):17-22. Review. No abstract available.

PMID:
20429154
3.

How much cancer can EPA regulate away?

Gough M.

Risk Anal. 1990 Mar;10(1):1-6. No abstract available.

PMID:
2330433
4.

Combating environmental causes of cancer.

Tarone RE, McLaughlin JK.

N Engl J Med. 2011 Jun 9;364(23):2266-7; author reply 2267-8. doi: 10.1056/NEJMc1103912#SA2. No abstract available.

PMID:
21651409
5.

US Environmental Protection Agency's revised guidelines for Carcinogen Risk Assessment: incorporating mode of action data.

Dellarco VL, Wiltse JA.

Mutat Res. 1998 Sep 20;405(2):273-7. No abstract available.

PMID:
9748625
6.

Reality versus extrapolation: an academic perspective of cancer risk regulation.

Waddell WJ.

Drug Metab Rev. 1996 Feb-May;28(1-2):181-95. Review. No abstract available.

PMID:
8744595
7.

Approaches to cancer assessment in EPA's Integrated Risk Information System.

Gehlhaus MW 3rd, Gift JS, Hogan KA, Kopylev L, Schlosser PM, Kadry AR.

Toxicol Appl Pharmacol. 2011 Jul 15;254(2):170-80. doi: 10.1016/j.taap.2010.10.019. Epub 2010 Oct 27. Review.

PMID:
21034767
8.

TCE, designated a known carcinogen, now the focus of ongoing research.

McNeil C.

J Natl Cancer Inst. 2013 Oct 16;105(20):1518-9. doi: 10.1093/jnci/djt296. Epub 2013 Sep 30. No abstract available.

PMID:
24082065
9.

A toxicologist's view of cancer risk assessment.

Rozman KK, Kerecsen L, Viluksela MK, Osterle D, Deml E, Viluksela M, Stahl BU, Greim H, Doull J.

Drug Metab Rev. 1996 Feb-May;28(1-2):29-52. Review. No abstract available.

PMID:
8744588
10.

Man-made vitreous fibres.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans..

IARC Monogr Eval Carcinog Risks Hum. 2002;81:1-381. Review. No abstract available.

11.

Combating environmental causes of cancer.

Christiani DC.

N Engl J Med. 2011 Mar 3;364(9):791-3. doi: 10.1056/NEJMp1006634. No abstract available.

PMID:
21366471
12.

Carcinogen risk assessment in the U.S. Environmental Protection Agency.

Albert RE.

Crit Rev Toxicol. 1994;24(1):75-85.

PMID:
8172652
13.

Childhood cancer etiology: recent reports.

Davies SM, Ross JA.

Med Pediatr Oncol. 2003 Jan;40(1):35-8. No abstract available.

PMID:
12426684
14.

Cancer risk in the work place, including asbestos.

Nicholson WJ.

Eur J Cancer Prev. 1996 Oct;5(5):393-6. Review. No abstract available.

PMID:
8972272
15.

Trichloroethylene health risks--state of the science.

Scott CS, Cogliano VJ.

Environ Health Perspect. 2000 May;108 Suppl 2:159-60. No abstract available.

16.

Environmental risk assessment of arsenic and fluoride in the Chaco Province, Argentina: research advances.

Buchhamer EE, Blanes PS, Osicka RM, Giménez MC.

J Toxicol Environ Health A. 2012;75(22-23):1437-50. doi: 10.1080/15287394.2012.721178.

PMID:
23095162
17.

Arsenic risk assessment.

Carlson-Lynch H, Beck BD, Boardman PD.

Environ Health Perspect. 1994 Apr;102(4):354-6.

18.

Reducing uncertainty in risk assessment by using specific knowledge to replace default options.

McClellan RO.

Drug Metab Rev. 1996 Feb-May;28(1-2):149-79. Review.

PMID:
8744594
19.

Environmental factors in cancer: radon.

Lubin JH.

Rev Environ Health. 2010 Jan-Mar;25(1):33-8. Review. No abstract available.

PMID:
20429156
20.

Implementation of EPA Revised Cancer Assessment Guidelines: Incorporation of Mechanistic and Pharmacokinetic Data.

Page NP, Singh DV, Farland W, Goodman JI, Conolly RB, Andersen ME, Clewell HJ, Frederick CB, Yamasaki H, Lucier G.

Fundam Appl Toxicol. 1997 May;37(1):16-36.

PMID:
9193920

Supplemental Content

Support Center